查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067686

病理學領域人工智慧市場規模、佔有率和趨勢分析報告：按組件、技術、應用、最終用途、地區和細分市場分類（2026-2033 年）

AI In Pathology Market Size, Share & Trends Analysis Report By Component (Software, Hardware), By Technology (Machine Learning, Computer Vision-based Image Analysis), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

病理學領域人工智慧市場概述

2025年全球病理學領域的人工智慧市場規模估計為1.6825億美元，預計到2033年將達到11.5155億美元。

預計從 2026 年到 2033 年，該市場將以 27.42% 的複合年成長率成長。推動市場成長的關鍵因素包括對精準醫療的需求不斷成長、慢性病盛行率上升以及技術進步。

此外，病理基礎設施數位化、積極的監管政策以及跨行業合作的進步正在強化市場環境。精準醫療日益成長的需求是人工智慧（AI）在病理產業發展的關鍵驅動力之一。透過將組織病理影像分析與基因組數據結合，人工智慧能夠更準確地進行疾病亞型分類和預後預測，從而為每位患者提供個人化治療。例如，2025年7月，LG AI研究院發布了EXAONE Path 2.0，這是其病理學人力智慧模型的升級版，旨在改善癌症診斷和藥物研發。該系統結合了對整個切片影像和較小區域的分析，以避免特徵崩壞並保留上下文資訊。模型使用包括DNA、RNA和全切片病理影像在內的多組體學資料進行訓練，能夠分析基因變異、基因表現和細微的組織變化，預測準確率高達78.4%。

此外，人工智慧研究和醫療數位轉型 (DX) 專案資金的增加，以及遠端病理學的日益普及，也推動了人工智慧工具的大規模部署。例如，Proscia 於 2025 年 3 月成功資金籌措。這將使該公司能夠進一步整合人工智慧功能，並加強與安捷倫科技和西門子醫療等原始設備製造商 (OEM) 的夥伴關係。

此外，檢查室工作流程的最佳化和營運效率的提升也顯著推動了人工智慧病理解決方案的應用。利用人工智慧自動化組織分割、細胞計數和測量等常規任務，可以減少人工操作和人為錯誤，使病理學家能夠將更多時間投入更複雜的病例。例如，Owkin公司於2025年1月發布了關於數位病理學和人工智慧解決方案的新見解，重點關注了病理學家因工作量和診斷複雜性而日益加劇的職業倦怠等挑戰。他們的人工智慧診斷技術支援對全切片影像進行快速解讀、生物標記篩檢和患者預後預測，從而實現精準腫瘤學。

此外，產業夥伴關係正在強化市場環境。製藥公司正與人工智慧開發公司合作，將數位病理學整合到臨床試驗和藥物研發中。例如，2025年4月，Precision for Medicine與PathAI宣佈建立策略合作夥伴關係，共同開發創新型人工智慧技術，並將PathAI先進的數位病理學功能整合到Precision for Medicine的臨床試驗和生物檢體流程中。 Precision for Medicine可望透過利用PathAI的影像管理系統「AISight」和人工智慧演算法，結合整合的品管程序，提升生物檢體分析工作流程，從而提高數據的一致性和可靠性。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：病理學領域的人工智慧市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 病理學領域的人工智慧市場分析工具
  • 個案研究的啟示
  • 投資和資金籌措狀況
  • 技術分析：關鍵用例和應用領域

第4章：病理學領域的人工智慧市場：按組件分類的估算和趨勢分析

  • 全球病理學人工智慧市場：基於組件的波動分析
  • 全球病理學人工智慧市場：基於組件的規模和趨勢分析，2021-2033年
  • 軟體
    • 影像分析和模式識別
    • 預測分析工具
    • 工作流程自動化軟體
    • 診斷決策支持
  • 硬體
    • 全玻片成像（WSI）掃描儀
    • 數位病理系統
    • 人工智慧顯微鏡
  • 服務
    • 實施與整合
    • 諮詢和培訓
    • 託管人工智慧服務
    • 維護和支援

第5章：病理學領域的人工智慧市場：按技術分類的估算和趨勢分析

  • 全球病理學人工智慧市場：基於技術的波動分析
  • 全球病理學人工智慧市場：基於技術的規模和趨勢分析（2021-2033年）
  • 機器學習演算法
    • 深度學習
  • 自然語言處理（NLP）
  • 基於電腦視覺的圖像分析

第6章：病理學領域的人工智慧市場：按應用分類的估算和趨勢分析

  • 全球病理學人工智慧市場：基於應用的波動分析
  • 全球病理學人工智慧市場：基於應用的規模和趨勢分析（2021-2033年）
  • 疾病診斷與分類
  • 發現預後和預測生物標記
  • 數位幻燈片影像分析
  • 最佳化臨床工作流程
  • 藥物發現與研究病理學
  • 組織/細胞分析
  • 其他

第7章：病理學領域的人工智慧市場：按最終用途分類的估算和趨勢分析

  • 全球病理學人工智慧市場：按最終用途分類的波動分析
  • 全球病理學人工智慧市場：終端用戶規模和趨勢分析（2021-2033年）
  • 醫院/診斷檢查室
  • 生命科學公司
  • 研究機構和學術機構
  • 其他

第8章：病理學領域人工智慧市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • Leica Biosystems Nussloch GmbH（subsidiary of Danaher）
    • Koninklijke Philips NV
    • F. Hoffmann-La Roche Ltd.
    • PathAI
    • Proscia Inc.
    • Aiforia/Aiforia Technologies PLC
    • Ibex Medical Analytics
    • Mindpeak GmbH
    • Owkin, Inc.
    • Tempus AI
    • Indica Labs, LLC.
    • Qritive
Product Code: GVR-4-68040-758-8

AI In Pathology Market Summary

The global AI in pathology market size was estimated at USD 168.25 million in 2025 and is projected to reach USD 1151.55 million by 2033, growing at a CAGR of 27.42% from 2026 to 2033. Growing demand for precision medicine, rising prevalence of chronic diseases, technological advancements are significant factors contributing to market growth.

Moreover, the growing digitization of pathological infrastructure, supportive regulatory progress, and industry partnerships are strengthening the market environment. The growing demand for precision medicine is one of the significant drivers of artificial intelligence in pathology industry. AI facilitates tailored treatments by integrating histopathological image analysis with genomic data to provide more precise disease subtyping and prognosis. For instance, in July 2025, LG AI Research unveiled its upgraded pathology AI model, EXAONE Path 2.0, to enhance cancer diagnosis and drug development. The system combines analysis of both entire slide images and smaller patches to avoid feature collapse and preserve contextual information. Trained on multi-omics data, including DNA, RNA, and whole slide pathology images, the model analyzes genetic mutations, gene expression, and subtle tissue changes with 78.4% prediction accuracy.

In addition, growing funding for AI research and healthcare digital transformation programs, alongside rising adoption of telepathology, support the deployment of AI tools on a large scale. For instance, in March 2025, Proscia secured USD 50 million in funding to accelerate the adoption of its AI-powered Concentriq platform, an AI-driven pathology solution, to integrate more AI capabilities and leverage partnerships with OEMs like Agilent Technologies and Siemens Healthineers.

Workflow optimization and operational efficiency in laboratories also significantly fuel the adoption of AI pathology solutions. AI-driven automation of routine tasks such as tissue segmentation, cell counting, and measurement reduces manual labor and human error, allowing pathologists to devote more time to complex cases. For instance, in January 2025, Owkin unveiled new insights into digital pathology and AI solutions, highlighting challenges such as rising pathologist burnout due to workload and diagnostic complexity. Their AI diagnostics support quick interpretation of whole slide images, biomarker screening, and patient outcome predictions to enable precision oncology.

Furthermore, industry partnerships are strengthening the market environment. Pharmaceutical companies are collaborating with AI developers to incorporate digital pathology into clinical trials and drug development. For instance, in April 2025, Precision for Medicine and PathAI announced a strategic collaboration to develop novel AI technologies and integrate PathAI's advanced digital pathology capabilities into Precision for Medicine's clinical trial and biospecimen operations. Precision for Medicine is expected to leverage PathAI's AISight image management system and AI algorithms to enhance biospecimen analysis workflows with quality control steps, improving data consistency and reliability.

Global AI In Pathology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI inpathology market report based on component, technology, application, end use, and region.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
    • Image Analysis & Pattern Recognition
    • Predictive Analytics Tools
    • Workflow Automation Software
    • Diagnostic Decision Support
  • Hardware
    • Whole Slide Imaging (WSI) Scanners
    • Digital Pathology Systems
    • AI-Enabled Microscopes
  • Service
    • Implementation & Integration
    • Consulting & Training
    • Managed AI Services
    • Maintenance & Support
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
    • Deep Learning
    • Convolutional Neural Networks (CNNS)
    • Generative Adversarial Networks (GANS)
    • Recurrent Neural Networks (RNNS)
    • Other Neural Networks
  • Natural Language Processing (NLP)
  • Computer Vision-based Image Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis & Classification
  • Prognostic & Predictive Biomarker Discovery
  • Digital Slide Image Analysis
  • Clinical Workflow Optimization
  • Drug Discovery & Research Pathology
  • Tissue & Cell Analysis
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Diagnostic Laboratories
  • Life Sciences Companies
  • Research Institutes & Academic Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Pathology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for accurate and early disease detection
      • 3.2.1.2. Technological advancements in machine learning, natural language processing, and computer vision
      • 3.2.1.3. Increasing government initiatives and regulatory support
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data security and privacy concerns
      • 3.2.2.2. High costs of advanced devices
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI in Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
  • 3.4. Case Study Insights
    • 3.4.1. Building tools for machine learning and artificial intelligence in computational pathology
  • 3.5. Investment & funding scenario
  • 3.6. Technology Analysis: Key Use Cases and Application
    • 3.6.1. Machine Learning (ML)/Deep Learning
    • 3.6.2. Natural Language Processing (NLP)
    • 3.6.3. Computer Vision-based Image Analysis

Chapter 4. AI in Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Pathology Market Component Movement Analysis
  • 4.3. Global AI in Pathology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Image Analysis & Pattern Recognition
      • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Predictive Analytics Tools
      • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Workflow Automation Software
      • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Diagnostic Decision Support
      • 4.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Whole Slide Imaging (WSI) Scanners
      • 4.5.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.3. Digital Pathology Systems
      • 4.5.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.4. AI-Enabled Microscopes
      • 4.5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Implementation & Integration
      • 4.6.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.3. Consulting & Training
      • 4.6.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.4. Managed AI Services
      • 4.6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.5. Maintenance & Support
      • 4.6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Pathology Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Pathology Market Technology Movement Analysis
  • 5.3. Global AI in Pathology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. Machine Learning Algorithms
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 5.4.2. Deep learning
      • 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.2. Convolutional Neural Networks (CNNS)
        • 5.4.2.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.3. Generative Adversarial Networks (GANS)
        • 5.4.2.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.4. Recurrent Neural Networks (RNNS)
        • 5.4.2.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
      • 5.4.2.5. Other Neural Networks
        • 5.4.2.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Natural Language Processing (NLP)
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Computer Vision-based Image Analysis
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Pathology Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Pathology Market Application Movement Analysis
  • 6.3. Global AI in Pathology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Disease Diagnosis & Classification
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Prognostic & Predictive Biomarker Discovery
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Digital Slide Image Analysis
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Clinical Workflow Optimization
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Drug Discovery & Research Pathology
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.9. Tissue & Cell Analysis
    • 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI in Pathology Market End Use Movement Analysis
  • 7.3. Global AI in Pathology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Diagnostic Laboratories
    • 7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Life Sciences Companies
    • 7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Research Institutes & Academic Centers
    • 7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. AI in Pathology Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Koninklijke Philips N.V.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. F. Hoffmann-La Roche Ltd.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. PathAI
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Proscia Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Aiforia/ Aiforia Technologies PLC
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Ibex Medical Analytics
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Mindpeak GmbH
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Owkin, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Tempus AI
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Indica Labs, LLC.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Qritive
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI in pathology market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 4 Global AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 6 Global AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 9 North America AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 11 North America AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 13 U.S. AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 14 U.S. AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Canada AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Canada AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 19 Canada AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 21 Mexico AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 22 Mexico AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 26 Europe AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 27 Europe AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Europe AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 30 UK AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 31 UK AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 32 UK AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Germany AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 34 Germany AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 35 Germany AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 36 Germany AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 38 France AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 39 France AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 40 France AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 42 Italy AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 43 Italy AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 44 Italy AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Spain AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Spain AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Spain AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 50 Denmark AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 51 Denmark AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 52 Denmark AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 54 Sweden AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 55 Sweden AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 58 Norway AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 59 Norway AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 60 Norway AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 67 China AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 68 China AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 69 China AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Japan AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 72 Japan AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Japan AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 75 India AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 76 India AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 77 India AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 79 South Korea AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 80 South Korea AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 81 South Korea AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 83 Australia AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 84 Australia AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 85 Australia AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 87 Thailand AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 88 Thailand AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Thailand AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 92 Latin America AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 93 Latin America AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 96 Brazil AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 97 Brazil AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 100 Argentina AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 101 Argentina AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA AI in pathology market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 105 MEA AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 106 MEA AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 107 MEA AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 109 South Africa AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 110 South Africa AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 117 UAE AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 118 UAE AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 119 UAE AI in pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait AI in pathology market, by component, 2021 - 2033 (USD Million)
  • Table 121 Kuwait AI in pathology market, by application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait AI in pathology market, by technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait AI in pathology market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 AI in pathology market: Market outlook
  • Fig. 6 AI in pathology market: Segment outlook
  • Fig. 7 AI in pathology market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 AI in pathology market driver impact
  • Fig. 10 AI in pathology market restraint impact
  • Fig. 11 AI in pathology market: Component outlook and key takeaways
  • Fig. 12 AI in pathology market: Component movement analysis
  • Fig. 13 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Image analysis & pattern recognition market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Predictive analytics tools market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Workflow automation software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Diagnostic decision support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Whole slide imaging (WSI) scanners market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Digital pathology systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 AI-enabled microscopes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Implementation & integration market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Consulting & training market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Managed AI services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Maintenance & support market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 AI in pathology market: Technology outlook and key takeaways
  • Fig. 28 AI in pathology market: Technology movement analysis
  • Fig. 29 Machine learning algorithms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Deep learning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Convolutional neural networks (CNNS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Generative adversarial networks (GANS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Recurrent neural networks (RNNS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Other neural networks market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Natural language processing (NLP) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Computer vision-based image analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 AI in pathology market: Application outlook and key takeaways
  • Fig. 38 AI in pathology market: Application movement analysis
  • Fig. 39 Disease diagnosis & classification market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Prognostic & predictive biomarker discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Predictive analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Digital slide image analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Clinical workflow optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Drug discovery & research pathology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Tissue & cell analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 AI in pathology market: End use outlook and key takeaways
  • Fig. 48 AI in pathology market: End use movement analysis
  • Fig. 49 Hospitals & diagnostic laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Life sciences companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Research institutes & academic centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Global AI in pathology market: Regional outlook and key takeaways
  • Fig. 54 Global AI in pathology market: Regional movement analysis
  • Fig. 55 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 U.S. key country dynamics
  • Fig. 57 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Canada key country dynamics
  • Fig. 59 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico key country dynamics
  • Fig. 61 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 UK key country dynamics
  • Fig. 64 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Germany key country dynamics
  • Fig. 66 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 France key country dynamics
  • Fig. 68 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Italy key country dynamics
  • Fig. 70 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Spain key country dynamics
  • Fig. 72 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Denmark key country dynamics
  • Fig. 74 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Sweden key country dynamics
  • Fig. 76 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Norway key country dynamics
  • Fig. 78 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Japan key country dynamics
  • Fig. 81 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 China key country dynamics
  • Fig. 83 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 India key country dynamics
  • Fig. 85 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Thailand key country dynamics
  • Fig. 87 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Brazil key country dynamics
  • Fig. 94 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Argentina key country dynamics
  • Fig. 96 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 South Africa key country dynamics
  • Fig. 99 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Saudi Arabia key country dynamics
  • Fig. 101 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 UAE key country dynamics
  • Fig. 103 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Kuwait key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)